{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:19:44Z","timestamp":1793312384644,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:00:00Z","timestamp":1557792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Innate lymphoid cells (ILCs) are crucial for the immune surveillance at mucosal sites. ILCs coordinate early eradication of pathogens and contribute to tissue healing and remodeling, features that are dysfunctional in patients with cystic fibrosis (CF). The mechanisms by which ILCs contribute to CF-immunopathology are ill-defined. Here, we show that group 2 ILCs (ILC2s) transdifferentiated into IL-17-secreting cells in the presence of the epithelial-derived\u00a0cytokines IL-1\u03b2, IL-23 and TGF-\u03b2. This conversion is abrogated by IL-4 or vitamin D3. IL-17 producing ILC2s induce IL-8 secretion by epithelial cells and their presence in nasal polyps of CF patients is associated with neutrophilia. Our data suggest that ILC2s undergo transdifferentiation in CF nasal polyps in response to local cytokines, which are induced by infectious agents.<\/jats:p>","DOI":"10.1038\/s41467-019-09883-7","type":"journal-article","created":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T10:04:05Z","timestamp":1557828245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":150,"title":["IL-1\u03b2, IL-23, and TGF-\u03b2 drive plasticity of human ILC2s towards IL-17-producing ILCs in nasal inflammation"],"prefix":"10.1038","volume":"10","author":[{"given":"Korneliusz","family":"Golebski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier R.","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"van Tol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2909-8481","authenticated-orcid":false,"given":"Balthasar A.","family":"Heesters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Aglmous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal M. A.","family":"Kradolfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medya M.","family":"Shikhagaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Seys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. W.","family":"Hellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis M.","family":"van Drunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske J.","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hergen","family":"Spits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3133-6450","authenticated-orcid":false,"given":"Suzanne M.","family":"Bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,14]]},"reference":[{"key":"9883_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrg3849","volume":"16","author":"GR Cutting","year":"2015","unstructured":"Cutting, G. R. Cystic fibrosis genetics: from molecular understanding to clinical application. Nat. Rev. Genet. 16, 45\u201356 (2015).","journal-title":"Nat. Rev. Genet."},{"key":"9883_CR2","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.4305","volume":"23","author":"L Romani","year":"2017","unstructured":"Romani, L. et al. Thymosin alpha1 represents a potential potent single-molecule-based therapy for cystic fibrosis. Nat. Med. 23, 590\u2013600 (2017).","journal-title":"Nat. Med."},{"issue":"4","key":"9883_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jcf.2017.04.013","volume":"16","author":"Alison DaCosta","year":"2017","unstructured":"DaCosta A. et al. Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. J. Cyst. Fibros. 16, 483\u2013487 (2017).","journal-title":"Journal of Cystic Fibrosis"},{"key":"9883_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10096-016-2621-0","volume":"35","author":"DH Limoli","year":"2016","unstructured":"Limoli, D. H. et al. Staphylococcus aureus and Pseudomonas aeruginosa co-infection is associated with cystic fibrosis-related diabetes and poor clinical outcomes. Eur. J. Clin. Microbiol Infect. Dis. 35, 947\u2013953 (2016).","journal-title":"Eur. J. Clin. Microbiol Infect. Dis."},{"key":"9883_CR5","doi-asserted-by":"crossref","unstructured":"Jennings, M. T., Dasenbrook E. C., Lechtzin N., Boyle M. P. & Merlo C. A. Risk factors for persistent methicillin-resistant Staphylococcus aureus infection in cystic fibrosis. J. Cyst. Fibros. 16, 681\u2013686 (2017).","DOI":"10.1016\/j.jcf.2017.04.010"},{"key":"9883_CR6","doi-asserted-by":"publisher","first-page":"361-364","DOI":"10.1007\/s00106-005-1328-9","volume":"54","author":"A Koitschev","year":"2006","unstructured":"Koitschev, A. et al. [Routine otorhinolaryngological examination in patients with cystic fibrosis]. HNO 54, 361-364\u2013366, 368 (2006).","journal-title":"HNO"},{"key":"9883_CR7","unstructured":"Fokkens, W. J. et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol. Suppl.\u00a050, 3\u2013298 (2012)."},{"key":"9883_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jcf.2004.06.006","volume":"3","author":"JM Courtney","year":"2004","unstructured":"Courtney, J. M., Ennis, M. & Elborn, J. S. Cytokines and inflammatory mediators in cystic fibrosis. J. Cyst. Fibros. 3, 223\u2013231 (2004).","journal-title":"J. Cyst. Fibros."},{"key":"9883_CR9","first-page":"61","volume":"3","author":"JL Taylor-Cousar","year":"2010","unstructured":"Taylor-Cousar, J. L., Von Kessel, K. A., Young, R. & Nichols, D. P. Potential of anti-inflammatory treatment for cystic fibrosis lung disease. J. Inflamm. Res. 3, 61\u201374 (2010).","journal-title":"J. Inflamm. Res."},{"key":"9883_CR10","doi-asserted-by":"publisher","first-page":"e114884","DOI":"10.1371\/journal.pone.0114884","volume":"9","author":"J Palomo","year":"2014","unstructured":"Palomo, J. et al. Role of IL-1beta in experimental cystic fibrosis upon P. aeruginosa infection. PLoS ONE 9, e114884 (2014).","journal-title":"PLoS ONE"},{"key":"9883_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10791","volume":"7","author":"RG Iannitti","year":"2016","unstructured":"Iannitti, R. G. et al. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat. Commun. 7, 10791 (2016).","journal-title":"Nat. Commun."},{"key":"9883_CR12","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1164\/rccm.201206-1150OC","volume":"187","author":"K Tiringer","year":"2013","unstructured":"Tiringer, K. et al. A Th17-and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa Infection. Am. J. Resp. Crit. Care 187, 621\u2013629 (2013).","journal-title":"Am. J. Resp. Crit. Care"},{"key":"9883_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1183\/09031936.00067110","volume":"37","author":"M Brodlie","year":"2011","unstructured":"Brodlie, M. et al. Raised interleukin-17 is immunolocalised to neutrophils in cystic fibrosis lung disease. Eur. Respir. J. 37, 1378\u20131385 (2011).","journal-title":"Eur. Respir. J."},{"key":"9883_CR14","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1128\/IAI.00284-16","volume":"84","author":"D Hsu","year":"2016","unstructured":"Hsu, D. et al. Interleukin-17 pathophysiology and therapeutic intervention in cystic fibrosis lung infection and inflammation. Infect. Immun. 84, 2410\u20132421 (2016).","journal-title":"Infect. Immun."},{"key":"9883_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nm.3423","volume":"20","author":"HY Kim","year":"2014","unstructured":"Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54\u201361 (2014).","journal-title":"Nat. Med."},{"key":"9883_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jaci.2016.09.009","volume":"138","author":"J Mjosberg","year":"2016","unstructured":"Mjosberg, J. & Spits, H. Human innate lymphoid cells. J. Allergy Clin. Immunol. 138, 1265\u20131276 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"9883_CR17","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","volume":"174","author":"E Vivier","year":"2018","unstructured":"Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054\u20131066 (2018).","journal-title":"Cell"},{"key":"9883_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature14189","volume":"517","author":"D Artis","year":"2015","unstructured":"Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293\u2013301 (2015).","journal-title":"Nature"},{"key":"9883_CR19","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nm.3892","volume":"21","author":"GF Sonnenberg","year":"2015","unstructured":"Sonnenberg, G. F. & Artis, D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 21, 698\u2013708 (2015).","journal-title":"Nat. Med."},{"key":"9883_CR20","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink, J. H. et al. Interleukin-12 and -23 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146\u2013160 (2015).","journal-title":"Immunity"},{"key":"9883_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ni.3443","volume":"17","author":"JS Silver","year":"2016","unstructured":"Silver, J. S. et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat. Immunol. 17, 626\u2013635 (2016).","journal-title":"Nat. Immunol."},{"key":"9883_CR22","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/ni.3444","volume":"17","author":"SM Bal","year":"2016","unstructured":"Bal, S. M. et al. IL-1beta, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat. Immunol. 17, 636\u2013645 (2016).","journal-title":"Nat. Immunol."},{"key":"9883_CR23","doi-asserted-by":"publisher","first-page":"1086-+","DOI":"10.1016\/j.cell.2017.02.021","volume":"168","author":"AI Lim","year":"2017","unstructured":"Lim, A. I. et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 168, 1086\u2212+ (2017).","journal-title":"Cell"},{"key":"9883_CR24","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","volume":"37","author":"J Mjosberg","year":"2012","unstructured":"Mjosberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649\u2013659 (2012).","journal-title":"Immunity"},{"key":"9883_CR25","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ni.2104","volume":"12","author":"JM Mjosberg","year":"2011","unstructured":"Mjosberg, J. M. et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat. Immunol. 12, 1055\u20131062 (2011).","journal-title":"Nat. Immunol."},{"key":"9883_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/ni0816-1005a","volume":"17","author":"Y Ohne","year":"2016","unstructured":"Ohne, Y. et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity (vol 17, pg 646, 2016). Nat. Immunol. 17, 1005\u20131005 (2016).","journal-title":"Nat. Immunol."},{"key":"9883_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.0801986","volume":"183","author":"HW Qin","year":"2009","unstructured":"Qin, H. W. et al. TGF-beta promotes Th17 cell development through inhibition of SOCS3. J. Immunol. 183, 97\u2013105 (2009).","journal-title":"J. Immunol."},{"key":"9883_CR28","doi-asserted-by":"publisher","first-page":"18460","DOI":"10.1073\/pnas.0809850105","volume":"105","author":"T Korn","year":"2008","unstructured":"Korn, T. et al. IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3(+) regulatory T cells. Proc Natl Acad. Sci. USA 105, 18460\u201318465 (2008).","journal-title":"Proc Natl Acad. Sci. USA"},{"key":"9883_CR29","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.4049\/jimmunol.1601421","volume":"198","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. Cutting edge: notch signaling promotes the plasticity of group-2 innate lymphoid cells. J. Immunol. 198, 1798\u20131803 (2017).","journal-title":"J. Immunol."},{"key":"9883_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3078","volume":"16","author":"YF Huang","year":"2015","unstructured":"Huang, Y. F. et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u2018inflammatory' type 2 innate lymphoid cells. Nat. Immunol. 16, 161 (2015).","journal-title":"Nat. Immunol."},{"key":"9883_CR31","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/ni.3447","volume":"17","author":"Y Ohne","year":"2016","unstructured":"Ohne, Y. et al. IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat. Immunol. 17, 646\u2013655 (2016).","journal-title":"Nat. Immunol."},{"key":"9883_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","volume":"181","author":"MS Maddur","year":"2012","unstructured":"Maddur, M. S., Miossec, P., Kaveri, S. V. & Bayry, J. Th17 Cells biology, pathogenesis of autoimrnune and inflammatory diseases, and therapeutic strategies. Am. J. Pathol. 181, 8\u201318 (2012).","journal-title":"Am. J. Pathol."},{"key":"9883_CR33","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/ni.3272","volume":"16","author":"T Ebihara","year":"2015","unstructured":"Ebihara, T. et al. Runx3 specifies lineage commitment of innate lymphoid cells. Nat. Immunol. 16, 1124\u20131133 (2015).","journal-title":"Nat. Immunol."},{"key":"9883_CR34","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.cell.2016.07.043","volume":"166","author":"M Gury-BenAri","year":"2016","unstructured":"Gury-BenAri, M. et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166, 1231\u20131246 (2016). e1213.","journal-title":"Cell"},{"key":"9883_CR35","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.4049\/jimmunol.1102918","volume":"188","author":"F Zhao","year":"2012","unstructured":"Zhao, F. et al. Human CCR4(+)CCR6(+)Th17 cells suppress autologous CD8(+) T cell responses. J. Immunol. 188, 6055\u20136062 (2012).","journal-title":"J. Immunol."},{"key":"9883_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4049\/jimmunol.180.1.122","volume":"180","author":"HW Lim","year":"2008","unstructured":"Lim, H. W., Lee, J., Hillsamer, P. & Kim, C. H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3(+) regulatory T cells. J. Immunol. 180, 122\u2013129 (2008).","journal-title":"J. Immunol."},{"key":"9883_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.aam5809","volume":"359","author":"YF Huang","year":"2018","unstructured":"Huang, Y. F. et al. S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science 359, 114\u2013119 (2018).","journal-title":"Science"},{"key":"9883_CR38","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.3390\/ijms150915011","volume":"15","author":"XH Gai","year":"2014","unstructured":"Gai, X. H., Tu, K. S., Lu, Z. T. & Zheng, X. MRC2 expression correlates with TGF beta 1 and survival in hepatocellular carcinoma. Int. J. Mol. Sci. 15, 15011\u201315025 (2014).","journal-title":"Int. J. Mol. Sci."},{"key":"9883_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/ni.3368","volume":"17","author":"AK Bjorklund","year":"2016","unstructured":"Bjorklund, A. K. et al. The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing. Nat. Immunol. 17, 451\u2013460 (2016).","journal-title":"Nat. Immunol."},{"key":"9883_CR40","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.aaa4812","volume":"348","author":"MR Hepworth","year":"2015","unstructured":"Hepworth, M. R. et al. Immune tolerance. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4(+) T cells. Science 348, 1031\u20131035 (2015).","journal-title":"Science"},{"issue":"5","key":"9883_CR41","doi-asserted-by":"publisher","first-page":"1761-1773.e6","DOI":"10.1016\/j.jaci.2017.09.050","volume":"141","author":"Jovana Maric","year":"2018","unstructured":"Maric, J. et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J. Allergy Clin. Immunol. 141, 1761\u20131773 (2017).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"9883_CR42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jcf.2011.11.007","volume":"11","author":"L Derycke","year":"2012","unstructured":"Derycke, L., Zhang, N., Holtappels, G., Dutre, T. & Bachert, C. IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. J. Cyst. Fibros. 11, 193\u2013200 (2012).","journal-title":"J. Cyst. Fibros."},{"key":"9883_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1165\/rcmb.2005-0022OC","volume":"33","author":"A van den Berg","year":"2005","unstructured":"van den Berg, A. et al. Interleukin-17 induces hyperresponsive interleukin-8 and interleukin-6 production to tumor necrosis factor-alpha in structural lung cells. Am. J. Respir. Cell Mol. Biol. 33, 97\u2013104 (2005).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"9883_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/apa.13424","volume":"105","author":"K Douros","year":"2016","unstructured":"Douros, K. Cystic fibrosis and vitamin D: the quest for more pieces of the puzzle. Acta Paediatr. 105, 854 (2016).","journal-title":"Acta Paediatr."},{"key":"9883_CR45","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S2213-2600(17)30306-5","volume":"5","author":"DA Jolliffe","year":"2017","unstructured":"Jolliffe, D. A. et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir. Med. 5, 881\u2013890 (2017).","journal-title":"Lancet Respir. Med."},{"key":"9883_CR46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1590\/S0066-782X2012005000019","volume":"98","author":"M Milovanovic","year":"2012","unstructured":"Milovanovic, M. et al. Vitamin D deficiency is associated with increased IL-17 and Tnf alpha levels in patients with chronic heart failure. Arq. Bras. Cardiol. 98, 259\u2013264 (2012).","journal-title":"Arq. Bras. Cardiol."},{"key":"9883_CR47","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.jaci.2017.01.045","volume":"141","author":"V Konya","year":"2018","unstructured":"Konya, V. et al. Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells. J. Allergy Clin. Immun. 141, 279\u2013292 (2018).","journal-title":"J. Allergy Clin. Immun."},{"key":"9883_CR48","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/all.12440","volume":"69","author":"D Miljkovic","year":"2014","unstructured":"Miljkovic, D. et al. Association between group 2 innate lymphoid cells enrichment, nasal polyps and allergy in chronic rhinosinusitis. Allergy 69, 1154\u20131161 (2014).","journal-title":"Allergy"},{"key":"9883_CR49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cea.12462","volume":"45","author":"J Ho","year":"2015","unstructured":"Ho, J. et al. Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. Clin. Exp. Allergy 45, 394\u2013403 (2015).","journal-title":"Clin. Exp. Allergy"},{"key":"9883_CR50","doi-asserted-by":"crossref","unstructured":"Hoorweg, K. et al. Functional differences between human NKp44(-) and NKp44(+) RORC+ innate lymphoid cells. Front. Immunol. 3, 72 (2012).","DOI":"10.3389\/fimmu.2012.00072"},{"key":"9883_CR51","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1084\/jem.20101712","volume":"208","author":"A Geremia","year":"2011","unstructured":"Geremia, A. et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 208, 1127\u20131133 (2011).","journal-title":"J. Exp. Med."},{"key":"9883_CR52","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1177\/039463201102400215","volume":"24","author":"C Colombo","year":"2011","unstructured":"Colombo, C. et al. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis. Int. J. Immunopathol. Pharm. 24, 423\u2013432 (2011).","journal-title":"Int. J. Immunopathol. Pharm."},{"key":"9883_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/alr.21274","volume":"4","author":"RJ Schlosser","year":"2014","unstructured":"Schlosser, R. J., Soler, Z. M., Schmedes, G. W., Storck, K. & Mulligan, J. K. Impact of vitamin D deficiency upon clinical presentation in nasal polyposis. Int. Forum Allergy Rhinol. 4, 196\u2013199 (2014).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"9883_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2500\/ajra.2017.31.4484","volume":"31","author":"I Konstantinidis","year":"2017","unstructured":"Konstantinidis, I. et al. Vitamin D(3) deficiency and its association with nasal polyposis in patients with cystic fibrosis and patients with chronic rhinosinusitis. Am. J. Rhinol. Allergy 31, 395\u2013400 (2017).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"9883_CR55","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/mi.2014.94","volume":"8","author":"J Chen","year":"2015","unstructured":"Chen, J., Waddell, A., Lin, Y. D. & Cantorna, M. T. Dysbiosis caused by vitamin D receptor deficiency confers colonization resistance to Citrobacter rodentium through modulation of innate lymphoid cells. Mucosal Immunol. 8, 618\u2013626 (2015).","journal-title":"Mucosal Immunol."},{"key":"9883_CR56","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/intimm\/dxr045","volume":"23","author":"D Bruce","year":"2011","unstructured":"Bruce, D., Yu, S. H., Ooi, J. H. & Cantorna, M. T. Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23, 519\u2013528 (2011).","journal-title":"Int. Immunol."},{"key":"9883_CR57","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MCP.0000000000000435","volume":"24","author":"I Kortekaas Krohn","year":"2018","unstructured":"Kortekaas Krohn, I., Bal, S. M. & Golebski, K. The role of innate lymphoid cells in airway inflammation: evolving paradigms. Curr. Opin. Pulm. Med. 24, 11\u201317 (2018).","journal-title":"Curr. Opin. Pulm. Med"},{"issue":"2","key":"9883_CR58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.chest.2018.04.036","volume":"154","author":"Martina Gentzsch","year":"2018","unstructured":"Gentzsch, M., Mall, M. A. Ion channel modulators in cystic fibrosis. Chest\u00a0154, 383\u2013393 (2018).","journal-title":"Chest"},{"key":"9883_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep25937","volume":"6","author":"NI Lore","year":"2016","unstructured":"Lore, N. I. et al. IL-17A impairs host tolerance during airway chronic infection by Pseudomonas aeruginosa. Sci. Rep. 6, 25937 (2016).","journal-title":"Sci. Rep."},{"key":"9883_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/ni.3057","volume":"16","author":"JK Bando","year":"2015","unstructured":"Bando, J. K., Liang, H. E. & Locksley, R. M. Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine. Nat. Immunol. 16, 153 (2015).","journal-title":"Nat. Immunol."},{"issue":"1","key":"9883_CR61","doi-asserted-by":"publisher","first-page":"229-244.e9","DOI":"10.1016\/j.jaci.2018.03.007","volume":"143","author":"Ting Cai","year":"2019","unstructured":"Cai, T. et al. IL-17-producing ST2(+) group 2 innate lymphoid cells play a pathogenic role in lung inflammation. J. Allergy Clin. Immunol. 143, 229\u2013244 (2018).","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"9883_CR62","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1126\/science.aac9593","volume":"350","author":"G Gasteiger","year":"2015","unstructured":"Gasteiger, G., Fan, X. Y., Dikiy, S., Lee, S. Y. & Rudensky, A. Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981\u2013985 (2015).","journal-title":"Science"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09883-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09883-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T23:37:02Z","timestamp":1671233822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-09883-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["9883"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-09883-7","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,14]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.S. is an employee and shareholder of AIMM therapeutics. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2162"}}